Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline.
Share this article
Corporate
Score 65
Neutral
Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline
Mar 14, 2026 03:30 UTC
LLY, ABVAX, BMY
Short term
Related Articles
Score 45
Billionaires Tepper and Platt Shift AI Holdings Amid Nvidia Exit and 40,000% Gainer Surge
Mar 15, 22:35
Score 85
Bullish
Nvidia Just Spent More Than Iceland's Economy In 30 Days — What Is Jensen Huang Building?
Mar 15, 22:30
Score 65
Bullish
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares
Mar 15, 22:27
Score 85
Bullish
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share
Mar 15, 22:20
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.